Transcept Pharma (TSPT) Taps John Kollins as CBO

June 4, 2012 4:05 PM EDT
Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), reports that John A. Kollins will join the Company, effective June 1, 2012, and serve as Senior Vice President and Chief Business Officer. In this new position, Mr. Kollins will have primary responsibility for business and corporate development activities and report to Glenn A. Oclassen, President and Chief Executive Officer of Transcept.

Kollins provided strategy, business development and transaction services to life science companies via Parnassus Advisors, the consulting and advisory firm he established, and Locust Walk Partners. From 2007 to 2009, he served successively as Chief Business Officer, Chief Operating Officer, and Chief Executive Officer and Director of OXiGENE, a publicly-held biopharmaceutical company.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Management Changes

Add Your Comment